The short answer for both injection types

After a hyaluronic acid (HA) viscosupplementation injection, most patients can return to light activity within 24–48 hours. After an Arthrosamid hydrogel injection, the advised low-activity window is 14 days — roughly six times longer. Neither protocol means bed rest, but both mean no deliberate exercise in the immediate post-procedure period.

| | Hyaluronic acid (HA) | Arthrosamid (iPAAG) | |---|---|---| | Immediate rest | 24–48 hours reduced activity | 24 hours complete rest | | No strenuous activity | 1–2 days | 14 days ('be deliberately lazy') | | Light walking | Permitted once comfortable | Brief, necessary only | | Return to exercise | Days | Graduated from week 3 onwards |

The difference reflects biology, not excessive caution. Arthrosamid is a non-biodegradable hydrogel that must physically integrate into the synovial lining; premature loading risks displacing it before that process is complete. Hyaluronic acid, by contrast, is gradually absorbed and does not depend on mechanical integration.

Why Arthrosamid's rest window is stricter than HA

The distinction comes down to what each substance does inside the joint after injection.

Hyaluronic acid closely resembles the glycosaminoglycan chains already present in healthy synovial fluid. Once injected, it disperses through the joint space, temporarily restoring lubrication and reducing friction between articular surfaces. Because it is bioabsorbable, it is gradually processed by the body over days to weeks — there is no anchoring phase, and no mechanical relationship between early activity and long-term efficacy.

Arthrosamid is composed of 2.5% cross-linked polyacrylamide and 97.5% water. This non-biodegradable hydrogel is not absorbed; instead, it is designed to integrate structurally into the synovial lining of the joint. Think of this as the hydrogel settling and anchoring into the soft tissue environment — a process that takes time and that is disrupted by high joint loads before it is complete. Strenuous activity during those first 14 days risks mechanically displacing the gel before integration has occurred, which would undermine the intended long-term effect from a single injection.

This is the clinical rationale behind the stricter aftercare: the 14-day rest window is not precautionary overcaution but a biological requirement specific to a non-absorbable device designed to provide relief for up to three years from one treatment.

The Arthrosamid aftercare timeline week by week

Breaking the 14-day window into its component phases makes it easier to plan around.

First 24 hours

Complete rest is the starting point. Once the local anaesthetic wears off — usually within a few hours of leaving the clinic — discomfort, swelling, and stiffness typically increase. Paracetamol is suitable for pain during this phase; ibuprofen is preferred if swelling is present, as it acts on inflammation rather than simply masking pain. Avoid stairs unnecessarily, and keep the leg elevated where practical.

Days 1–3

No strenuous activity: that means no running, gym sessions, heavy lifting, kneeling, or prolonged standing. Short, flat walks to the kitchen or bathroom are distinct from deliberate exercise — brief movement for essential tasks is acceptable; setting out for a walk as exercise is not. NSAIDs are recommended for up to seven days post-injection under the procedural protocol, covering both inflammation control and infection-risk reduction.

Days 4–14: 'be deliberately lazy'

The instruction from the aftercare protocol is intentionally straightforward — be lazy. Desk-based work is often possible during this window; jobs involving standing for long periods, climbing, kneeling, or carrying are not. Cycling, swimming, and similar leisure activities should wait. The guide here is the written aftercare document, not the patient's own pain threshold: feeling comfortable is not the same as the hydrogel being integrated.

Six-week clinical review

A formal review at around six weeks is standard. This is the appropriate point at which return to sport, gym work, and higher-load activity is individually assessed — accounting for baseline knee function, osteoarthritis severity, and any coexisting diagnosis. No single universal return date applies after day 14; meaningful pain reduction in clinical trials typically begins around week four, but structured progression beyond that is a decision made with the treating clinician, not assumed.

Viscosupplementation (HA) aftercare — a more permissive timeline

HA aftercare is simpler to summarise than Arthrosamid's. Most protocols advise 24–48 hours of relative rest after each injection, avoiding strenuous activity — running, heavy gym sessions, high-impact sport — during that short window. After this, gentle walking and low-impact movement can typically resume, with higher-intensity exercise phased back in gradually over the following days.

Where a course of injections is prescribed — some multi-injection HA protocols involve two or three sessions spaced a week apart — the same 24–48 hour guidance applies around each individual session, not only the first.

Because hyaluronic acid is bioabsorbable and does not need a structural integration phase, the activity restrictions are shorter and less prescriptive than those for Arthrosamid. That said, HA guidance is not uniformly standardised across practices: the written instructions provided at the time of injection take precedence, since specific protocols vary by clinician and product. Patients should follow those directly rather than relying on general timelines.

Benefit typically becomes noticeable within a few weeks as the hyaluronic acid augments synovial fluid and reduces joint friction. The Cochrane systematic review by Bellamy et al. (2006) and subsequent meta-analyses support efficacy across both single- and multi-injection protocols, placing viscosupplementation on a well-established clinical evidence base for symptomatic knee osteoarthritis.

What 'rest' actually means — walking, work, and daily life

Planning the first two weeks around the Arthrosamid rest window looks very different depending on how someone earns a living. An office-based role — seated, screen-facing, with occasional short walks to a printer or meeting room — is broadly compatible with the integration period from around day three or four onwards. A job involving prolonged standing at a workbench, repeated stair-climbing, kneeling on a floor, or manual lifting is not, and patients in those roles should plan for signed-off absence for most or all of the 14-day window rather than assuming they can manage.

For HA viscosupplementation, the planning horizon is shorter: 24–48 hours of reduced activity around each injection session is the working guide, after which most daily and occupational tasks can resume, with high-impact activity phased back in over the following days.

Return to sport after either injection type is not governed by a fixed calendar date. For Arthrosamid, the six-week clinical review is the right moment to raise this — by then, the treating clinician can weigh knee response, baseline function, and any coexisting diagnosis against what the patient wants to return to. For HA, the appropriate time to seek sport clearance is a follow-up call to the clinic once the short rest window has passed and symptoms have settled. Neither injection comes with a blanket clearance date.

Pain management and warning signs after a knee injection

Some degree of soreness, stiffness, and swelling in the days after a knee injection is expected — it does not signal that something has gone wrong. The needle itself causes a minor local reaction, and for Arthrosamid in particular, the joint may feel more uncomfortable once the local anaesthetic wears off, typically within a few hours of leaving clinic.

For most patients, paracetamol taken regularly for the first two to three days manages background discomfort well. If swelling is pronounced, ibuprofen is the more useful addition because it acts on inflammation rather than simply dampening pain perception; this is why aftercare protocols commonly recommend it specifically when the joint looks or feels puffy. NSAIDs are typically advised for up to seven days post-Arthrosamid injection, both for inflammation control and as part of the infection-risk protocol. Patients for whom ibuprofen is contraindicated — those with certain gastrointestinal, renal, or cardiovascular conditions — should discuss alternatives with their clinician beforehand. TENS (transcutaneous electrical nerve stimulation) is available as a supplementary option at MSK House for patients who prefer a non-pharmacological adjunct.

When to seek urgent advice

Mild temporary flares — a brief increase in aching or puffiness a day or two after the injection — sit within normal range. The symptoms that warrant prompt contact are qualitatively different: pain that worsens rather than plateaus, heat around the joint, spreading redness, or swelling that keeps increasing, particularly if accompanied by fever, chills, or a general sense of feeling unwell.

For Arthrosamid specifically, these red-flag symptoms carry added weight. Because the hydrogel is non-biodegradable and integrates with synovial tissue, a joint infection — though uncommon — is considerably harder to eradicate than after an absorbable injection, and may require surgical intervention if it takes hold. Prophylactic intravenous antibiotics at the time of the injection are standard practice precisely to reduce this risk. If any of the above warning signs develop, patients should contact the clinic that performed the injection without delay rather than waiting to see whether symptoms settle.